1,540
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Trends among platelet function, arterial calcium, and vascular function measures

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Article: 2238835 | Received 10 Nov 2022, Accepted 14 Jul 2023, Published online: 23 Aug 2023

References

  • Berger M, Kleber ME, Delgado GE, Marz W, Andreas M, Hellstern P, Marx N, Schuett KA. Trimethylamine N-Oxide and adenosine diphosphate-induced platelet reactivity are independent risk factors for cardiovascular and all-cause mortality. Circ Res. 2020;126(5):660–13. doi:10.1161/CIRCRESAHA.119.316214.
  • Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost. 2011;9(1):49–56. doi:10.1111/j.1538-7836.2010.04110.x.
  • Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, Gibson CM, Group TS. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI trials). Am J Cardiol. 2006;98(1):1–5. doi:10.1016/j.amjcard.2006.01.046.
  • Puurunen MK, Hwang SJ, Larson MG, Vasan RS, O’Donnell CJ, Tofler G, Johnson AD. ADP platelet hyperreactivity predicts cardiovascular disease in the FHS (Framingham heart study). J Am Heart Assoc. 2018;7(5). doi:10.1161/JAHA.118.008522.
  • Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa Do Amaral RJ, Granjeiro JM, Borojevic R. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. doi:10.1186/scrt218.
  • Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000;6(4):460–3. doi:10.1038/74725.
  • Ho-Tin-Noe B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost. 2011;9(Suppl 1):56–65. doi:10.1111/j.1538-7836.2011.04317.x.
  • Rodrigues SF, Granger DN. Blood cells and endothelial barrier function. Tissue Barriers. 2015;3(1–2):e978720. doi:10.4161/21688370.2014.978720.
  • Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol. 2012;590(5):1023–34. doi:10.1113/jphysiol.2011.225417.
  • Reininger AJ. VWF attributes–impact on thrombus formation. Thromb Res. 2008;122(Suppl 4):S9–13. doi:10.1016/S0049-3848(08)70028-8.
  • Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 1996;88(9):3456–64. doi:10.1182/blood.V88.9.3456.bloodjournal8893456.
  • Pushin DM, Salikhova TY, Zlobina KE, Guria GT. Platelet activation via dynamic conformational changes of von Willebrand factor under shear. PLoS One. 2020;15(6):e0234501. doi:10.1371/journal.pone.0234501.
  • Nomura S. Microparticle and atherothrombotic diseases. J Atheroscler Thromb. 2016;23(1):1–9. doi:10.5551/jat.32326.
  • Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236–41. doi:10.1161/01.HYP.37.5.1236.
  • Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001;21(12):2046–50. doi:10.1161/hq1201.100226.
  • Zaid M, Fujiyoshi A, Kadota A, Abbott RD, Miura K. Coronary artery calcium and carotid artery intima media thickness and plaque: clinical use in need of clarification. J Atheroscler Thromb. 2017;24(3):227–39. doi:10.5551/jat.RV16005.
  • Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham heart study. Hypertension. 2004;43(6):1239–45. doi:10.1161/01.HYP.0000128420.01881.aa.
  • Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, Flaker GC, Pfeffer MA. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and ventricular enlargement. Circulation. 1997;96(12):4254–60. doi:10.1161/01.CIR.96.12.4254.
  • Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation. 2010;121(4):505–11. doi:10.1161/CIRCULATIONAHA.109.886655.
  • Zachariah JP, Xanthakis V, Larson MG, Vita JA, Sullivan LM, Smith HM, Safa R, Peng X, Hamburg N, Levy D, et al. Circulating vascular growth factors and central hemodynamic load in the community. Hypertension. 2012;59(4):773–9. doi: 10.1161/HYPERTENSIONAHA.111.179242.
  • Hamburg NM, Palmisano J, Larson MG, Sullivan LM, Lehman BT, Vasan RS, Levy D, Mitchell GF, Vita JA, Benjamin EJ. Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension. 2011;57(3):390–6. doi:10.1161/HYPERTENSIONAHA.110.160812.
  • Jakubowski M, Turek-Jakubowska A, Szahidewicz-Krupska E, Gawrys K, Gawrys J, Doroszko A. Profiling the endothelial function using both peripheral artery tonometry (EndoPAT) and laser doppler flowmetry (LD) - complementary studies or waste of time? Microvasc Res. 2020;130:104008. doi:10.1016/j.mvr.2020.104008.
  • Lavi S, Alemayehu M, Puka K, Wall S, Lavi R. Association between administration of ticagrelor and microvascular endothelial function. JAMA Cardiol. 2017;2(9):1042–4. doi:10.1001/jamacardio.2017.2378.
  • Liberts EA, Willoughby SR, Kennedy JA, Horowitz JD. Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectoris. Eur J Pharmacol. 2007;560(1):49–55. doi:10.1016/j.ejphar.2007.01.001.
  • Mannaerts D, Faes E, Goovaerts I, Stoop T, Cornette J, Gyselaers W, Spaanderman M, Van Craenenbroeck EM, Jacquemyn Y. Flow-mediated dilation and peripheral arterial tonometry are disturbed in preeclampsia and reflect different aspects of endothelial function. Am J Physiol Regul Integr Comp Physiol. 2017;313(5):R518–R25. doi:10.1152/ajpregu.00514.2016.
  • Rull G, Mohd-Zain ZN, Shiel J, Lundberg MH, Collier DJ, Johnston A, Warner TD, Corder R. Effects of high flavanol dark chocolate on cardiovascular function and platelet aggregation. Vascul Pharmacol. 2015;71:70–8. doi:10.1016/j.vph.2015.02.010.
  • Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willoughby SR. Detrimental effects of energy drink consumption on platelet and endothelial function. Am J Med. 2010;123(2):184–7. doi:10.1016/j.amjmed.2009.09.013.
  • Eigenbrodt ML, Sukhija R, Rose KM, Tracy RE, Couper DJ, Evans GW, Bursac Z, Mehta JL. Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study. Cardiovasc Ultrasound. 2007;5:11. doi:10.1186/1476-7120-5-11.
  • Portilla-Fernandez E, Klarin D, Hwang SJ, Biggs ML, Bis JC, Weiss S, Rospleszcz S, Natarajan P, Hoffmann U, Rogers IS, et al. Genetic and clinical determinants of abdominal aortic diameter: genome-wide association studies, exome array data and Mendelian randomization study. Hum Mol Genet. 2022;31(20):3566–79. doi: 10.1093/hmg/ddac051.
  • Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham study. Am J Public Health Nations Health. 1951;41(3):279–81. doi:10.2105/AJPH.41.3.279.
  • Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ, D’Agostino RB Sr., Fox CS, Larson MG, Murabito JM, et al. The third generation cohort of the national heart, lung, and blood institute’s Framingham heart study: design, recruitment, and initial examination. Am J Epidemiol. 2007;165(11):1328–35. doi: 10.1093/aje/kwm021.
  • Tsao CW, Vasan RS. Cohort profile: The Framingham heart study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol. 2015;44(6):1800–13. doi:10.1093/ije/dyv337.
  • Tsao CW, Pencina KM, Massaro JM, Benjamin EJ, Levy D, Vasan RS, Hoffmann U, O’Donnell CJ, Mitchell GF. Cross-sectional relations of arterial stiffness, pressure pulsatility, wave reflection, and arterial calcification. Arterioscler Thromb Vasc Biol. 2014;34(11):2495–500. doi:10.1161/ATVBAHA.114.303916.
  • Grech J, Chan MV, Ochin C, Lachapelle A, Thibord F, Schneider Z, Nkambule BB, Armstrong PCJ, de Melendez CW, Tucker KL, et al. Serotonin-affecting antidepressant use in relation to platelet reactivity. Clin Pharma Therapeutics. 2021;111(4):909–18. doi: 10.1002/cpt.2517.
  • Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost. 2013;11(6):1183–9. doi: 10.1111/jth.12231.
  • Chan MV, Armstrong PC, Papalia F, Kirkby NS, Warner TD. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. Platelets. 2011;22(7):485–94. doi:10.3109/09537104.2011.592958.
  • nplr: N-Parameter Logistic Regression [2016].
  • Monaco G, Chen H, Poidinger M, Chen J, de Magalhaes JP, Larbi A. flowAI: automatic and interactive anomaly discerning tools for flow cytometry data. Bioinformatics. 2016;32(16):2473–80. doi:10.1093/bioinformatics/btw191.
  • Mitchell GF, Guo CY, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D. Cross-sectional correlates of increased aortic stiffness in the community: the Framingham heart study. Circulation. 2007;115(20):2628–36. doi:10.1161/CIRCULATIONAHA.106.667733.
  • Zachariah JP, Rong J, Larson MG, Hamburg NM, Benjamin EJ, Vasan RS, Mitchell GF. Metabolic predictors of change in vascular function: prospective associations from a community-based cohort. Hypertension. 2018;71(2):237–42. doi:10.1161/HYPERTENSIONAHA.117.10054.
  • Mitchell GF, Wang N, Palmisano JN, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS. Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the Framingham heart study. Circulation. 2010;122(14):1379–86. doi:10.1161/CIRCULATIONAHA.109.914507.
  • Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32. doi:10.1016/0735-1097(90)90282-T.
  • Chen Z, Mondal NK, Zheng S, Koenig SC, Slaughter MS, Griffith BP, Wu ZJ. High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity. Platelets. 2019;30(1):112–19. doi:10.1080/09537104.2017.1384542.
  • Reininger AJ, Heijnen HF, Schumann H, Specht HM, Schramm W, Ruggeri ZM. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood. 2006;107(9):3537–45. doi:10.1182/blood-2005-02-0618.
  • McCrary JK, Nolasco LH, Hellums JD, Kroll MH, Turner NA, Moake JL. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. Ann Biomed Eng. 1995;23(6):787–93. doi:10.1007/BF02584477.
  • Sochi T. Non-Newtonian rheology in blood circulation. arXiv: Fluid Dynamics. 2013;1–26. doi:10.48550/arXiv.1306.2067.
  • Chirumamilla AP, Maehara A, Mintz GS, Mehran R, Kanwal S, Weisz G, Hassanin A, Hakim D, Guo N, Baber U, et al. High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. JACC Cardiovasc Imaging. 2012;5(5):540–9. doi: 10.1016/j.jcmg.2011.12.019.
  • Tselepis AD, John Chapman M. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler Suppl. 2002;3(4):57–68. doi:10.1016/S1567-5688(02)00045-4.
  • Zimmerman GA, Prescott SM, McIntyre TM. Platelet-activating factor and cell associated mediator of inflammation. In: Gallin J, Goldstein I, and Snyderman R, editors. Inflammation: basic principles and clinical correlates. 2nd. New York: Raven Press; 1992. p. 149–76.
  • Marx C, Novotny J, Salbeck D, Zellner KR, Nicolai L, Pekayvaz K, Kilani B, Stockhausen S, Burgener N, Kupka D, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134(21):1859–72. doi: 10.1182/blood.2019000518.
  • Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 2014;276(6):618–32. doi:10.1111/joim.12296.
  • Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood. 2014;123(18):2768–76. doi:10.1182/blood-2013-10-463646.
  • Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A. 1994;91(19):8767–71. doi:10.1073/pnas.91.19.8767.
  • Jin HY, Weir-McCall JR, Leipsic JA, Son JW, Sellers SL, Shao M, Blanke P, Ahmadi A, Hadamitzky M, Kim YJ, et al. The relationship between coronary calcification and the natural history of coronary artery disease. JACC Cardiovasc Imaging. 2021;14(1):233–42. doi: 10.1016/j.jcmg.2020.08.036.
  • Lee SH, Lee MY, Shin SY, Lee WS, Kim SW, Park SJ, Kim JS, Sung KC. Relationship between cardiovascular calcium and atrial fibrillation. J Clin Med. 2022;11(2):371. doi:10.3390/jcm11020371.
  • Tanne D, Tenenbaum A, Shemesh J, Schwammenthal Y, Fisman EZ, Schwammenthal E, Adler Y. Calcification of the thoracic aorta by spiral computed tomography among hypertensive patients: associations and risk of ischemic cerebrovascular events. Int J Cardiol. 2007;120(1):32–7. doi:10.1016/j.ijcard.2006.08.010.
  • Blomberg BA, de Jong PA, Thomassen A, Lam MGE, Vach W, Olsen MH, Mali W, Narula J, Alavi A, Hoilund-Carlsen PF. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study. Eur J Nucl Med Mol Imaging. 2017;44(2):249–58. doi:10.1007/s00259-016-3552-9.
  • Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens. 2001;19(3):381–7. doi:10.1097/00004872-200103000-00005.
  • Yamasaki F, Furuno T, Sato K, Zhang D, Nishinaga M, Sato T, Doi Y, Sugiura T. Association between arterial stiffness and platelet activation. J Hum Hypertens. 2005;19(7):527–33. doi:10.1038/sj.jhh.1001861.
  • Motau TH, Norton GR, Mmopi KN, Bello H, Peterson VR, Libhaber C, Sadiq E, Naran R, Da Silva Fernandes D, Masiu M, et al. Relations of aortic stiffness with arterial damage beyond brachial pressure are both dependent and independent of central arterial pulsatile load. J Hypertens. 2021;39(4):718–28. doi: 10.1097/HJH.0000000000002695.
  • Baldassarre D, Hamsten A, Veglia F, de Faire U, Humphries SE, Smit AJ, Giral P, Kurl S, Rauramaa R, Mannarino E, et al. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (carotid intima media thickness [IMT] and IMT-Progression as predictors of vascular events in a high risk European population) study. J Am Coll Cardiol. 2012;60(16):1489–99. doi: 10.1016/j.jacc.2012.06.034.
  • Nasir K, Ziffer JA, Cainzos-Achirica M, Ali SS, Feldman DI, Arias L, Saxena A, Feldman T, Cury R, Budoff MJ, et al. The Miami heart study (MiHeart) at Baptist Health South Florida, a prospective study of subclinical cardiovascular disease and emerging cardiovascular risk factors in asymptomatic young and middle-aged adults: The Miami heart study: rationale and design. Am J Prev Cardiol. 2021;7:100202. doi:10.1016/j.ajpc.2021.100202.
  • Addison C, Campbell Jenkins BW, White M, Thigpen Odom D, Fortenberry M, Wilson G, McCoy P, Young L, Woodberry C, Herron K, et al. Twenty years of leading the way among cohort studies in community-driven outreach and engagement: Jackson state university/Jackson heart study. Int J Environ Res Public Health. 2021;18(2):696. doi: 10.3390/ijerph18020696.
  • Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, et al. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991;1(3):263–76. doi: 10.1016/1047-2797(91)90005-W.
  • Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr., Kronmal R, Liu K, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871–81. doi: 10.1093/aje/kwf113.
  • Wolak A, Gransar H, Thomson LE, Friedman JD, Hachamovitch R, Gutstein A, Shaw LJ, Polk D, Wong ND, Saouaf R, et al. Aortic size assessment by noncontrast cardiac computed tomography: normal limits by age, gender, and body surface area. JACC Cardiovasc Imaging. 2008;1(2):200–9. doi: 10.1016/j.jcmg.2007.11.005.
  • Turkbey EB, Jain A, Johnson C, Redheuil A, Arai AE, Gomes AS, Carr J, Hundley WG, Teixido-Tura G, Eng J, et al. Determinants and normal values of ascending aortic diameter by age, gender, and race/ethnicity in the multi-ethnic study of atherosclerosis (MESA). J Magn Reson Imaging. 2014;39(2):360–8. doi: 10.1002/jmri.24183.
  • Pham MHC, Ballegaard C, de Knegt MC, Sigvardsen PE, Sorgaard MH, Fuchs A, Kuhl JT, Taudorf M, Nordestgaard BG, Kober LV, et al. Normal values of aortic dimensions assessed by multidetector computed tomography in the copenhagen general population study. Eur Heart J Cardiovasc Imaging. 2019;20(8):939–48. doi: 10.1093/ehjci/jez012.
  • Wong ND, Sciammarella M, Arad Y, Miranda-Peats R, Polk D, Hachamovich R, Friedman J, Hayes S, Daniell A, Berman DS. Relation of thoracic aortic and aortic valve calcium to coronary artery calcium and risk assessment. Am J Cardiol. 2003;92(8):951–5. doi:10.1016/S0002-9149(03)00976-7.
  • Hoffmann U, Massaro JM, Fox CS, Manders E, O’Donnell CJ. Defining normal distributions of coronary artery calcium in women and men (from the Framingham heart study). Am J Cardiol. 2008;102(9):1136–41. doi:10.1016/j.amjcard.2008.06.038.
  • Malhotra R, Mauer AC, Lino Cardenas CL, Guo X, Yao J, Zhang X, Wunderer F, Smith AV, Wong Q, Pechlivanis S, et al. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat Genet. 2019;51(11):1580–7. doi: 10.1038/s41588-019-0514-8.
  • de Haan A, Ahmadizar F, van der Most PJ, Thio CHL, Kamali Z, Ani A, Ghanbari M, Chaker L, van Meurs J, Ikram MK, et al. Genetic determinants of serum calcification propensity and cardiovascular outcomes in the general population. Front Cardiovasc Med. 2021;8:809717. doi:10.3389/fcvm.2021.809717.
  • Fung K, Ramirez J, Warren HR, Aung N, Lee AM, Tzanis E, Petersen SE, Munroe PB. Genome-wide association study identifies loci for arterial stiffness index in 127,121 UK Biobank participants. Sci Rep. 2019;9(1):9143. doi:10.1038/s41598-019-45703-0.
  • Rode M, Teren A, Wirkner K, Horn K, Kirsten H, Loeffler M, Scholz M, Pott J, Eller K. Genome-wide association analysis of pulse wave velocity traits provide new insights into the causal relationship between arterial stiffness and blood pressure. PLoS One. 2020;15(8):e0237237. doi:10.1371/journal.pone.0237237.
  • Mitchell GF, Verwoert GC, Tarasov KV, Isaacs A, Smith AV, Yasmin, Rietzschel ER, Tanaka T, Liu Y, Parsa A, et al. Common genetic variation in the 3’-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen consortium. Circ Cardiovasc Genet. 2012;5(1):81–90. doi: 10.1161/CIRCGENETICS.111.959817.
  • Keramati AR, Chen MH, Rodriguez BAT, Yanek LR, Bhan A, Gaynor BJ, Ryan K, Brody JA, Zhong X, Wei Q, et al. Genome sequencing unveils a regulatory landscape of platelet reactivity. Nat Commun. 2021;12(1):3626. doi: 10.1038/s41467-021-23470-9.
  • Rodriguez BAT, Bhan A, Beswick A, Elwood PC, Niiranen TJ, Salomaa V, FinnGen S, Tregouet DA, Morange PE, Civelek M, et al. A Platelet function modulator of thrombin activation is causally linked to cardiovascular disease and affects PAR4 receptor signaling. Am J Hum Genet. 2020;107(2):211–21. doi: 10.1016/j.ajhg.2020.06.008.
  • Larsson SC, Back M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J. 2020;41(2):221–6. doi:10.1093/eurheartj/ehz388.
  • Karhunen V, Bakker MK, Ruigrok YM, Gill D, Larsson SC. Modifiable risk factors for intracranial aneurysm and aneurysmal subarachnoid hemorrhage: a Mendelian randomization study. J Am Heart Assoc. 2021;10(22):e022277. doi:10.1161/JAHA.121.022277.
  • Lind L, Ingelsson M, Sundstrom J, Arnlov J. Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings. Open Heart. 2021;8(2):e001735. doi:10.1136/openhrt-2021-001735.
  • Migliacci R, Becattini C, Pesavento R, Davi G, Vedovati MC, Guglielmini G, Falcinelli E, Ciabattoni G, Dalla Valle F, Prandoni P, et al. Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica. 2007;92(6):812–8. doi: 10.3324/haematol.10872.
  • Heshmat-Ghahdarijani K, Jangjoo S, Amirpour A, Najafian J, Khosravi A, Heidarpour M, Hekmat M, Shafie D. Endothelial dysfunction in patients with lone atrial fibrillation. ARYA Atheroscler. 2020;16(6):278–83. doi:10.22122/arya.v16i6.2095.